$5.94
0.0%
Downside
Day's Volatility :4.81%
Upside
4.81%
17.51%
Downside
52 Weeks Volatility :39.36%
Upside
26.49%
Period | Electrocore | Index (Russel 2000) |
---|---|---|
3 Months | -9.31% | 0.0% |
6 Months | -12.77% | 0.0% |
1 Year | -0.83% | 0.0% |
3 Years | -61.18% | -22.3% |
Market Capitalization | 38.7M |
Book Value | $1.78 |
Earnings Per Share (EPS) | -2.05 |
Wall Street Target Price | 23.1 |
Profit Margin | -66.84% |
Operating Margin TTM | -42.21% |
Return On Assets TTM | -49.18% |
Return On Equity TTM | -153.49% |
Revenue TTM | 21.3M |
Revenue Per Share TTM | 3.25 |
Quarterly Revenue Growth YOY | 72.89999999999999% |
Gross Profit TTM | 7.2M |
EBITDA | -13.5M |
Diluted Eps TTM | -2.05 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.47 |
EPS Estimate Next Year | -0.55 |
EPS Estimate Current Quarter | -0.44 |
EPS Estimate Next Quarter | -0.35 |
What analysts predicted
Upside of 288.89%
Sell
Neutral
Buy
Electrocore is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Electrocore | -2.62% | -12.77% | -0.83% | -61.18% | -86.3% |
![]() Stryker Corporation | 12.3% | 0.36% | 24.19% | 28.8% | 65.26% |
![]() Boston Scientific Corp. | 10.6% | 20.32% | 51.42% | 80.93% | 95.5% |
![]() Edwards Lifesciences Corp. | 9.4% | -28.78% | -12.2% | -45.23% | -7.73% |
![]() Abbott Laboratories | 3.57% | -5.84% | 13.1% | -11.32% | 35.19% |
![]() Medtronic Plc | 10.85% | 5.57% | 12.46% | -33.2% | -16.71% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Electrocore | NA | NA | NA | -1.47 | -1.53 | -0.49 | NA | 1.78 |
![]() Stryker Corporation | 39.84 | 39.84 | 2.64 | 12.0 | 0.19 | 0.07 | 0.01 | 51.86 |
![]() Boston Scientific Corp. | 66.34 | 66.34 | 2.01 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
![]() Edwards Lifesciences Corp. | 26.3 | 26.3 | 3.2 | 2.69 | 0.22 | 0.12 | NA | 12.35 |
![]() Abbott Laboratories | 35.92 | 35.92 | 4.16 | 4.66 | 0.14 | 0.06 | 0.02 | 22.6 |
![]() Medtronic Plc | 30.16 | 30.16 | 1.66 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Electrocore | Buy | $38.7M | -86.3% | NA | -66.84% |
![]() Stryker Corporation | Buy | $136.8B | 65.26% | 39.84 | 16.12% |
![]() Boston Scientific Corp. | Buy | $120.2B | 95.5% | 66.34 | 12.0% |
![]() Edwards Lifesciences Corp. | Buy | $40.2B | -7.73% | 26.3 | 23.74% |
![]() Abbott Laboratories | Buy | $198.1B | 35.19% | 35.92 | 13.65% |
![]() Medtronic Plc | Buy | $115.3B | -16.71% | 30.16 | 12.06% |
Insights on Electrocore
Revenue is up for the last 8 quarters, 1.97M → 6.13M (in $), with an average increase of 14.7% per quarter
Netprofit is up for the last 6 quarters, -5.86M → -2.65M (in $), with an average increase of 17.7% per quarter
In the last 1 year, Boston Scientific Corp. has given 51.4% return, outperforming this stock by 52.2%
In the last 3 years, Boston Scientific Corp. has given 80.9% return, outperforming this stock by 142.1%
Awm Investment Company Inc
Vanguard Group Inc
International Assets Investment Management, LLC
Renaissance Technologies Corp
Geode Capital Management, LLC
Sontag Advisory LLC
electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.
Organization | Electrocore |
Employees | 68 |
CEO | Mr. Daniel S. Goldberger |
Industry | Health Technology |
A Spac I Acquisition Corp
$5.94
-1.0%
Keyarch Acquisition Corp
$5.94
-1.0%
Connexa Sports Technologies Inc
$5.94
-1.0%
Us Value Etf
$5.94
-1.0%
First Wave Biopharma Inc
$5.94
-1.0%
Global X Msci Next Emerging
$5.94
-1.0%
Fat Projects Acquisition Corp
$5.94
-1.0%
Capital Link Global Fintech
$5.94
-1.0%
Applied Uv Inc
$5.94
-1.0%